×
Innoviva SG&A Expenses 2010-2024 | INVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Innoviva sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
View More
Innoviva SG&A Expenses 2010-2024 | INVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Innoviva sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$757B
Novo Nordisk (NVO)
$483B
Johnson & Johnson (JNJ)
$377.3B
AbbVie (ABBV)
$354.3B
Merck (MRK)
$255.9B
Novartis AG (NVS)
$218.9B
AstraZeneca (AZN)
$200.6B
Pfizer (PFE)
$155.6B
Sanofi (SNY)
$131.3B